. Cell viability was determined following treatment with cisplatin for 24 h (A) IC50 = 10.8 µg/mL A2780CR; (B) IC50 = 4.9 µg/mL A2780. Figure S4 . Lactate dehydrogenase (LDH) assay. Effect of melittin on leakage of lactate dehydrogenase (LDH) from A2780 and A2780CR cell lines. The cells were incubated with melittin at different concentrations for 24 h. LDH activity was measured at 490 nm using an LDH cytotoxicity kit. Data were expressed as the mean ± SD of three independent experiments. Significant difference in LDH activity of melittin compared to untreated cells was tested by one-way ANOVA followed by Bonferroni's Multiple Comparison test to determine the differences between the experimental groups. Differences were considered significant at p < 0.001 ( * * * ) and ns: no significance. Figure S5 . Effect of Melittin on caspase-3 activity in A2780 and A2780CR cells. Both cell lines were incubated with different concentrations of melittin to measure caspase-3 activity. Staurosporine (10 µM) was used as a positive control. Following 6 and 24 h, cell were incubated with the caspase detection buffer and the fluorescence signal was measured following 1 h at 360 nm (excitation) and at 460 nm (emission). Data are presented as the fold change compare to untreated cells (negative control). Data were expressed as the mean ± SD of three independent experiments. Significant difference in caspase-3 activity of melittin compared to untreated cells was tested by one-way ANOVA followed by Bonferroni's Multiple Comparison test to determine the differences between the experimental groups. Differences were considered significant at the level of p < 0.05 and ns: no significance. 
